Quick update: brother DX 2018, G9 with Mets, Lupron, Docetaxel, Provenge, Zytiga,Xtandi, ARV 110 trial, Keytruda (msh2 +6, HTB). Keytruda lasted eight months with no side effects. Bone scan in November stable with ALP at 109. PSA rose to 45 and lymph nodes were all growing. I question whether lymph nodes were due to Keytruda or cancer growth. Regardless, MO took him off Keytruda
As you can see, he has run the gamut with TX. He will be the third person at Dana to participate in this phase 1 trial. It is scary and we know what he is faced with going into it. We have researched for hours and he has spoken to the research team. He is very brave and goes into it with a great attitude. He will never be one to say I wish I tried this or that as he has given it his all.
I wish we knew of somebody else who has done this trial. It’s hard going into some thing when you have no data. I do know there was a trial with nine men of which one passed and one went into remission. We’re shooting for the latter!!
Thank you all so much for your prayers and support. We will definitely update as we go along. He will do leukophorisis on Jan 18th with cells re-infused on March 1.